Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
Topic: ExploreIP
Industry welcomes new ISED marketplace for public sector IP, but still faces barriers leveraging university research
A new patent marketplace is one of the Government of Canada’s latest moves to leverage public sector investment in research to benefit Canadian businesses. Called ExploreIP, it is designed to help entrepreneurs discover and commercialize public sector intellectual property.